Annely M Richardson1, Ann M Moyer2, Linda Hasadsri2, Roshini S Abraham3. 1. Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA. 2. Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. 3. Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. abraham.roshini@mayo.edu.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of diagnostic testing in primary immunodeficiency and immune dysregulatory disorders (PIDDs), particularly focusing on flow cytometry and genetic techniques, utilizing specific examples of PIDDs. RECENT FINDINGS: Flow cytometry remains a vital tool in the diagnosis and monitoring of immunological diseases. Its utility ranges from cellular analysis and specific protein quantitation to functional assays and signaling pathway analysis. Mass cytometry combines flow cytometry and mass spectrometry to dramatically increase the throughput of multivariate single-cell analysis. Next-generation sequencing in combination with other molecular techniques and processing algorithms has become more widely available and identified the diverse and heterogeneous genetic underpinnings of these disorders. As the spectrum of disease is further clarified by increasing immunological, genetic, and epigenetic knowledge, the careful application of these diagnostic tools and bioinformatics will assist not only in our understanding of these complex disorders, but also enable the implementation of personalized therapeutic approaches for disease management.
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of diagnostic testing in primary immunodeficiency and immune dysregulatory disorders (PIDDs), particularly focusing on flow cytometry and genetic techniques, utilizing specific examples of PIDDs. RECENT FINDINGS: Flow cytometry remains a vital tool in the diagnosis and monitoring of immunological diseases. Its utility ranges from cellular analysis and specific protein quantitation to functional assays and signaling pathway analysis. Mass cytometry combines flow cytometry and mass spectrometry to dramatically increase the throughput of multivariate single-cell analysis. Next-generation sequencing in combination with other molecular techniques and processing algorithms has become more widely available and identified the diverse and heterogeneous genetic underpinnings of these disorders. As the spectrum of disease is further clarified by increasing immunological, genetic, and epigenetic knowledge, the careful application of these diagnostic tools and bioinformatics will assist not only in our understanding of these complex disorders, but also enable the implementation of personalized therapeutic approaches for disease management.
Authors: Dipika R Patel; Hui Yu; Lee-Jun C Wong; James R Lupski; Filiz O Seeborg; Nicholas L Rider; Caridad A Martinez; Jordan S Orange; Celine Hanson Journal: J Allergy Clin Immunol Pract Date: 2017-04-21
Authors: Carrie E Gifford; Elizabeth Weingartner; Joyce Villanueva; Judith Johnson; Kejian Zhang; Alexandra H Filipovich; Jack J Bleesing; Rebecca A Marsh Journal: Cytometry B Clin Cytom Date: 2014-02-19 Impact factor: 3.058
Authors: Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg Journal: J Clin Invest Date: 2010-03-08 Impact factor: 14.808
Authors: Joris M van Montfrans; Andy I M Hoepelman; Sigrid Otto; Marielle van Gijn; Lisette van de Corput; Roel A de Weger; Linda Monaco-Shawver; Pinaki P Banerjee; Elisabeth A M Sanders; Cornelia M Jol-van der Zijde; Michael R Betts; Jordan S Orange; Andries C Bloem; Kiki Tesselaar Journal: J Allergy Clin Immunol Date: 2011-12-24 Impact factor: 10.793
Authors: C Speckmann; K Lehmberg; M H Albert; R B Damgaard; M Fritsch; M Gyrd-Hansen; A Rensing-Ehl; T Vraetz; B Grimbacher; U Salzer; I Fuchs; H Ufheil; B H Belohradsky; A Hassan; C M Cale; M Elawad; B Strahm; S Schibli; M Lauten; M Kohl; J J Meerpohl; B Rodeck; R Kolb; W Eberl; J Soerensen; H von Bernuth; M Lorenz; K Schwarz; U Zur Stadt; S Ehl Journal: Clin Immunol Date: 2013-07-31 Impact factor: 3.969
Authors: Jet van der Spek; Rolf H H Groenwold; Mirjam van der Burg; Joris M van Montfrans Journal: J Clin Immunol Date: 2015-04-17 Impact factor: 8.317
Authors: Christopher C Dvorak; Elie Haddad; Rebecca H Buckley; Morton J Cowan; Brent Logan; Linda M Griffith; Donald B Kohn; Sung-Yun Pai; Luigi Notarangelo; William Shearer; Susan Prockop; Neena Kapoor; Jennifer Heimall; Sonali Chaudhury; David Shyr; Sharat Chandra; Geoff Cuvelier; Theodore Moore; Shalini Shenoy; Fred Goldman; Angela R Smith; Gauri Sunkersett; Mark Vander Lugt; Emi Caywood; Troy Quigg; Troy Torgerson; Shanmuganathan Chandrakasan; John Craddock; Blachy J Dávila Saldaña; Alfred Gillio; Evan Shereck; Victor Aquino; Kenneth DeSantes; Alan Knutsen; Monica Thakar; Lolie Yu; Jennifer M Puck Journal: J Allergy Clin Immunol Date: 2018-09-05 Impact factor: 10.793
Authors: Otavio Cabral-Marques; Lena F Schimke; Edgar Borges de Oliveira; Nadia El Khawanky; Rodrigo Nalio Ramos; Basel K Al-Ramadi; Gesmar Rodrigues Silva Segundo; Hans D Ochs; Antonio Condino-Neto Journal: Front Immunol Date: 2019-11-26 Impact factor: 7.561
Authors: Eleni Linskens; Annieck M Diks; Jana Neirinck; Martín Perez-Andres; Emilie De Maertelaere; Magdalena A Berkowska; Tessa Kerre; Mattias Hofmans; Alberto Orfao; Jacques J M van Dongen; Filomeen Haerynck; Jan Philippé; Carolien Bonroy Journal: Front Immunol Date: 2020-11-02 Impact factor: 7.561
Authors: Sara Bohnstedt Mørup; Lusine Nazaryan-Petersen; Migle Gabrielaite; Joanne Reekie; Hanne V Marquart; Hans Jakob Hartling; Rasmus L Marvig; Terese L Katzenstein; Tania N Masmas; Jens Lundgren; Daniel D Murray; Marie Helleberg; Line Borgwardt Journal: Front Immunol Date: 2022-06-30 Impact factor: 8.786